| Literature DB >> 3578580 |
R B Lydiard, M T Laraia, J C Ballenger, E F Howell.
Abstract
The authors relate their clinical experience with 46 panic disorder patients who were receiving 3-10 mg/day of alprazolam. Fifteen (33%) developed symptoms consistent with DSM-III criteria for major depression despite remission of their panic symptoms. Clinicians should be alert to this potentially reversible complication.Entities:
Mesh：
Substances：
Year: 1987 PMID： 3578580 DOI： 10.1176/ajp.144.5.664
Source DB: PubMed Journal: Am J Psychiatry ISSN： 0002-953X Impact factor: 18.112